en

PRODUCT DETAIL

Metoject PEN 17,5 mg injekčný roztok naplnený v injekčnom pere

Code 8926A
MA number 29/0009/14-S
Product Form: sol ira 15x0,35 ml/17,5 mg (pero napl. BD)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
MAH, country: medac Gesellschaft für klinische Spezialpräparate m.b.H., Germany
Therapeutic Class: 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AX Other immunosuppressants
L04AX03 Methotrexate
Shelf life: 24
Container: pre-filled pen
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(3) hybrid application
MA issued: 11.02.2014
Pediatric indication: Yes
Pediatric posology: Yes
Pediatric warnings: Yes
SPC: SPC_Metoject PEN injekčný roztok naplnený v injekčnom pere_10.2023.pdf  
PIL: PIL_Metoject PEN injekčný roztok naplnený v injekčnom pere_10.2023.pdf  
Safety feature Yes
Data update: 12.10.2023
eu-flag.png sk-flag.png